Danaher Corp (NYSE: DHR)’s stock price has increased by 0.53% compared to its previous closing price of $199.63. However, the company has seen a 1.59% increase in its stock price over the last five trading sessions. seekingalpha.com reported 2025-06-30 that Danaher is positioned for a revenue rebound, led by strong bioprocessing demand and resilient recurring sales, despite short-term headwinds in Life Sciences and China. Margin outlook is stable, supported by a $150M cost-cutting program and proactive tariff mitigation. Shares trade below their 5-year average P/E, offering compelling upside, as growth recovers and margin initiatives take hold.
Is It Worth Investing in Danaher Corp (NYSE: DHR) Right Now?
Danaher Corp (NYSE: DHR) has a price-to-earnings ratio that is above its average at 38.91x. The stock has a 36-month beta value of 0.74. Opinions on the stock are mixed, with 19 analysts rating it as a “buy,” 4 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for DHR is 652.19M, and at present, short sellers hold a 1.19% of that float. On July 09, 2025, the average trading volume of DHR was 4.03M shares.
DHR’s Market Performance
The stock of Danaher Corp (DHR) has seen a 1.59% increase in the past week, with a 4.44% rise in the past month, and a 10.40% gain in the past quarter. The volatility ratio for the week is 2.44%, and the volatility levels for the past 30 days are at 2.26% for DHR. The simple moving average for the past 20 days is 0.35% for DHR’s stock, with a -9.45% simple moving average for the past 200 days.
Analysts’ Opinion of DHR
Many brokerage firms have already submitted their reports for DHR stocks, with Barclays repeating the rating for DHR by listing it as a “Overweight.” The predicted price for DHR in the upcoming period, according to Barclays is $205 based on the research report published on April 10, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see DHR reach a price target of $260. The rating they have provided for DHR stocks is “Buy” according to the report published on March 21st, 2025.
Stifel gave a rating of “Buy” to DHR, setting the target price at $260 in the report published on March 14th of the current year.
DHR Trading at 2.41% from the 50-Day Moving Average
After a stumble in the market that brought DHR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.76% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DHR starting from RALES STEVEN M, who sale 1,250,000 shares at the price of $196.74 back on May 12 ’25. After this action, RALES STEVEN M now owns 3,105,808 shares of Danaher Corp, valued at $245,919,391 using the latest closing price.
Stock Fundamentals for DHR
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.6 for the gross margin
The net margin for Danaher Corp stands at 0.16. The total capital return value is set at 0.07. Equity return is now at value 7.22, with 4.63 for asset returns.
Based on Danaher Corp (DHR), the company’s capital structure generated 0.24 points at debt to capital in total, while cash flow to debt ratio is standing at 0.38. The debt to equity ratio resting at 0.32. The interest coverage ratio of the stock is 16.93.
Currently, EBITDA for the company is 7.28 billion with net debt to EBITDA at 2.02. When we switch over and look at the enterprise to sales, we see a ratio of 6.64. The receivables turnover for the company is 6.79for trailing twelve months and the total asset turnover is 0.3. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.43.
Conclusion
To sum up, Danaher Corp (DHR) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
